[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,194,112
  • Shares Outstanding, K 29,289
  • Annual Sales, $ 427,540 K
  • Annual Income, $ -21,020 K
  • EBIT $ -13 M
  • EBITDA $ 12 M
  • 60-Month Beta 2.06
  • Price/Sales 2.77
  • Price/Cash Flow 17.67
  • Price/Book 4.67

Options Overview Details

View History
  • Implied Volatility 79.21% (+4.26%)
  • Historical Volatility 209.56%
  • IV Percentile 61%
  • IV Rank 32.04%
  • IV High 133.95% on 10/23/25
  • IV Low 53.41% on 08/28/25
  • Expected Move (DTE 5) 4.08 (10.01%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 4,626
  • Volume Avg (30-Day) 2,453
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 22,611
  • Open Int (30-Day) 17,124
  • Expected Range 36.69 to 44.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.20
  • Number of Estimates 1
  • High Estimate $0.20
  • Low Estimate $0.20
  • Prior Year $0.50
  • Growth Rate Est. (year over year) -60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.21 +26.58%
on 05/06/26
73.46 -44.50%
on 04/21/26
-24.82 (-37.84%)
since 04/08/26
3-Month
32.21 +26.58%
on 05/06/26
97.30 -58.10%
on 02/11/26
-43.52 (-51.63%)
since 02/06/26
52-Week
32.21 +26.58%
on 05/06/26
170.87 -76.14%
on 12/02/25
-15.59 (-27.66%)
since 05/08/25

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS

NEW YORK , May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp.  ("GeneDx" or the "Company") (NASDAQ: WGS).  Such investors are advised...

WGS : 40.77 (+0.67%)
GeneDx Holdings Corp. (WGS) Under Investigation for Potential Securities Law Violations - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - May 7, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ: WGS) concerning...

WGS : 40.77 (+0.67%)
GENEDX HOLDINGS CORP. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

The law firm of Kirby McInerney LLP is investigating potential claims against GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ:WGS). The investigation concerns whether...

WGS : 40.77 (+0.67%)
Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GeneDx Holdings Corp. (“GeneDx” or the...

WGS : 40.77 (+0.67%)
GeneDx Holdings Corp. (WGS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ:  WGS ) investors concerning the Company’s possible...

WGS : 40.77 (+0.67%)
Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ:  WGS ) on behalf of investors concerning the Company’s...

WGS : 40.77 (+0.67%)
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GeneDx Holdings Corp.

MILWAUKEE , May 5, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against GeneDx (Nasdaq: WGS). The investigation results from inaccurate statements GeneDx may...

WGS : 40.77 (+0.67%)
GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

Reported total revenue of $102.3 million with 27% year-over-year growth in exome and genome revenue Reported exome and genome volume growth of 34% year-over-year...

WGS : 40.77 (+0.67%)
GeneDx: Can Prenatal Launch Justify the Reset or Is This Just a Slower Business Now?

Barchart Research What to Expect from WGS Earnings WGS Generated May 1, 2026 Current Price $65.38 EPS Estimate $$-0.06 Consensus Rating Strong Buy Average Move 21.39% GeneDx: Can Prenatal Launch Justify...

WGS : 40.77 (+0.67%)
GeneDx: Can Prenatal Launch Justify the Reset or Is This Just a Slower Business Now?

Barchart Research What to Expect from WGS Earnings WGS Generated May 1, 2026 Current Price $65.38 EPS Estimate $$-0.06 Consensus Rating Strong Buy Average Move 21.39% GeneDx: Can Prenatal Launch Justify...

WGS : 40.77 (+0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 46.47
2nd Resistance Point 44.05
1st Resistance Point 42.41
Last Price 40.77
1st Support Level 38.35
2nd Support Level 35.93
3rd Support Level 34.29

See More

52-Week High 170.87
Fibonacci 61.8% 117.90
Fibonacci 50% 101.54
Fibonacci 38.2% 85.18
Last Price 40.77
52-Week Low 32.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.